臺灣博碩士論文加值系統

研究背景：過去已有大量的研究發現，產前母親的塑化劑暴露與嬰兒的神經行為發展有負相關，然而在嬰兒出生後的塑化劑暴露與神經行為發展部分卻尚未被深入探究，且潛在的干擾因子，如：飲食習慣、環境因子等等，亦很少被納入實驗討論之中，故本研究著眼於探討嬰兒出生後的塑化劑暴露與神經行為發展之相關性，並且將飲食習慣、環境因子等干擾因子一併納入探討。

方法：本研究之參與個案來自台灣出生世代研究 (Taiwan Birth Panel study II，TBPS II；IRB No.: 201702038RINA)，此世代研究著重於探討產前及產後母親、嬰兒、及幼兒時期之健康情形與相關風險暴露；研究中使用Conners Kiddie Continuous Performance Test II (K-CPT II)評估幼兒之神經認知功能，以超高效液相層析串聯式質譜儀測量幼兒之塑化劑代謝物，並透過結構化問卷評估母親及幼兒之家庭背景、飲食情況、及環境因子等；統計部分使用單變量及多變量之線性及羅吉斯迴歸，調整潛在干擾因子，以估計塑化劑暴露與K-CPT II表現及注意力不足過動症 (Attention deficit hyperactivity disorder, ADHD)傾向之相關性。

結果：本研究共納入280對母親及幼兒。經調整干擾因子後之模型顯示，所有尿中塑化劑代謝物與K-CPT II T-scores有顯著之相關性皆為正相關，而一般而言K-CPT II T-scores越高即代表神經認知功能表現越差、ADHD的傾向越強；若針對K-CPT II中的各項目T-score作討論，顯示Hit reaction time T-score及Perseverations T-score此兩個項目於多變量線性迴歸模型之中，與最多尿中塑化劑代謝物有顯著正相關 (包含：MEP、MECPP、MCINP、MEHP)；針對尿中塑化劑代謝物作討論，則幼兒尿中Mono-carboxy-isononyl phthalate (MCINP)與最多K-CPT II T-score有顯著正相關 (包含：Detectability、Omissions、Perseverations、Hit reaction time、HRT standard deviation、HRT inter-stimulus interval change)；若針對ADHD傾向作討論，幼兒尿中Mono-benzyl phthalate (MBzP)是本研究有測量的六種塑化劑代謝物中，唯一一種於多變量羅吉斯迴歸模型中，與ADHD傾向有顯著相關之代謝物，其相關性為正相關，而有趣的是，幼兒尿中MBzP於多變量線性迴歸模型之中並未與任何K-CPT II T-score有顯著相關。

結論：本研究顯示幼兒塑化劑暴露與神經認知功能有顯著負相關、與ADHD傾向有顯著正相關，可能之因果關係及機制值得未來研究進一步探討。

Background: Although large number of studies have found that prenatal phthalate exposure was inversely associated with neurodevelopment in children, there were limited data concerning about postnatal phthalate exposure. Besides, the dietary exposure sources and environmental factors were rarely discussed within these studies. Hence, we aimed to gain a better understanding of the relationship between dietary habits, postnatal exposure to phthalates, and cognitive and behavioral development in offspring.

Methods: These participants of “Taiwan Birth Panel Study II, TBPS II” were followed up in 2017 (IRB No.: 201702038RINA), which is to investigate prenatal and postnatal factors on infant and early childhood health in National Taiwan University Hospital in 2009-2012. The neurocognitive function, phthalate exposure conditions, and other covariates were assessed by Conners Kiddie Continuous Performance Test II (K-CPT II), measurement of urine phthalate metabolites, and structured questionnaires, respectively. Univariate and multivariate linear and logistic regressions were used to examine the associations between phthalate exposure, K-CPT II performance and ADHD tendency.

Results: In this study, 280 paired samples with sufficient data of K-CPT II and phthalate metabolite concentrations were included, among 501 paired maternal and child samples enrolled in TBPS II. As higher T-scores generally mean poor performance, all the significant associations between urine phthalate metabolites and K-CPT II T-scores were positive associations in multivariate linear models. For K-CPT II performance variables, Hit reaction time T-score and Perseverations T-score were significantly positively-associated with the most phthalate metabolites, including MEP, MECPP, MCINP, and MEHP. For phthalate metabolites, child MCINP were significantly positively-associated with the most K-CPT II T scores, including T-scores of Detectability, Omissions, Perseverations, Hit reaction time, HRT standard deviation, and HRT inter-stimulus interval (ISI) change. In multivariate logistic models for ADHD tendency, child MBzP was the only phthalate metabolite tested that showed significantly positive association with ADHD tendency, after adjusting for covariates. Interestingly, MBzP was not significantly associated with any K-CPT II T score in the multivariate linear models.

Conclusions: Our study suggested that children phthalate exposure was significantly associated with neurocognitive function inversely, and ADHD tendency positively. Further large-scale prospective studies are warranted for investigation of the causal relationships and potential mechanisms.

口試委員會審訂書..................................... i
誌謝................................................ ii
中文摘要............................................. iii
英文摘要............................................. v
目錄................................................. vii
Chapter 1. Introduction............................. 1
Chapter 2. Material and method...................... 7
2.1. Participants.................................... 7
2.2. Measurement of neurocognitive function.......... 7
2.3. Measurement of phthalate metabolites............ 9
2.4. Statistical analysis............................ 10
Chapter 3. Results................................... 12
3.1. The descriptive characteristics of the study population........................................... 12
3.2. Distribution of K-CPT II data and urine phthalate metabolites.......................................... 12
3.3. Children phthalate metabolites in urine and K-CPT II performance.......................................... 13
3.4. Children phthalate metabolites in urine and ADHD tendency............................................. 15
Chapter 4. Discussion................................ 16
Chapter 5. Conclusions............................... 23
Chapter 6. Conflict of interests..................... 23
Tables............................................... 24
Table 1.............................................. 24
Table 2.............................................. 26
Table 3.............................................. 27
Table 4.............................................. 28
Table 5.............................................. 31
Table 6.............................................. 32
Supplementary Table S1............................... 33
Supplementary Table S2............................... 36
Supplementary Table S3............................... 39
Supplementary Table S4............................... 40
Supplementary Table S5............................... 42
Supplementary Table S6............................... 44
Supplementary Table S7............................... 45
Supplementary Table S8............................... 46
References........................................... 47

Aaron P, Joshi R, Palmer H, Smith N, Kirby E. 2002. Separating genuine cases of reading disability from reading deficits caused by predominantly inattentive adhd behavior. Journal of Learning Disabilities 35:425-436.
Andersen SL, Laurberg P, Wu CS, Olsen J. 2014. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: A danish nationwide cohort study. BJOG : an international journal of obstetrics and gynaecology 121:1365-1374.
Atkinson M, Hollis C. 2010. Nice guideline: Attention deficit hyperactivity disorder. Archives of Disease in Childhood-Education and Practice 95:24-27.
Balalian AA, Whyatt RM, Liu X, Insel BJ, Rauh VA, Herbstman J, et al. 2019. Prenatal and childhood exposure to phthalates and motor skills at age 11 years. Environmental research 171:416-427.
Banaschewski T, Becker K, Dopfner M, Holtmann M, Rosler M, Romanos M. 2017. Attention-deficit/hyperactivity disorder. Dtsch Arztebl Int 114:149-159.
Casas L, Tiesler C, Thiering E, Brüske I, Koletzko S, Bauer C-P, et al. 2013. Indoor factors and behavioural problems in children: The giniplus and lisaplus birth cohort studies. International journal of hygiene and environmental health 216:146-154.
CDC. 2019a. Attention-deficit / hyperactivity disorder (adhd).
CDC. 2019b. Fourth national report on human exposure to environmental chemicals.
Chen CC, Wang YH, Wang SL, Huang PC, Chuang SC, Chen MH, et al. 2017. Exposure sources and their relative contributions to urinary phthalate metabolites among children in taiwan. Int J Hyg Environ Health 220:869-879.
Conners CK, Epstein JN, Angold A, Klaric J. 2003. Continuous performance test performance in a normative epidemiological sample. Journal of abnormal child psychology 31:555-562.
Conners CK, Sitarenios G. 2011. Conners’ continuous performance test (cpt). In: Encyclopedia of clinical neuropsychology, (Kreutzer JS, DeLuca J, Caplan B, eds). New York, NY:Springer New York, 681-683.
Ejaredar M, Nyanza EC, Ten Eycke K, Dewey D. 2015. Phthalate exposure and childrens neurodevelopment: A systematic review. Environmental research 142:51-60.
Engel A, Buhrke T, Imber F, Jessel S, Seidel A, Volkel W, et al. 2017. Agonistic and antagonistic effects of phthalates and their urinary metabolites on the steroid hormone receptors eralpha, erbeta, and ar. Toxicology letters 277:54-63.
Engel SM, Villanger GD, Nethery RC, Thomsen C, Sakhi AK, Drover SS, et al. 2018. Prenatal phthalates, maternal thyroid function, and risk of attention-deficit hyperactivity disorder in the norwegian mother and child cohort. Environmental health perspectives 126:057004.
Gao H, Wu W, Xu Y, Jin Z, Bao H, Zhu P, et al. 2017. Effects of prenatal phthalate exposure on thyroid hormone concentrations beginning at the embryonic stage. Scientific reports 7:1-6.
Gillis JJ, Gilger JW, Pennington BF, DeFries JC. 1992. Attention deficit disorder in reading-disabled twins: Evidence for a genetic etiology. Journal of abnormal child psychology 20:303-315.
Goodman R, Stevenson J. 1989. A twin study of hyperactivity—ii. The aetiological role of genes, family relationships and perinatal adversity. Journal of Child psychology and Psychiatry 30:691-709.
Grindler NM, Vanderlinden L, Karthikraj R, Kannan K, Teal S, Polotsky AJ, et al. 2018. Exposure to phthalate, an endocrine disrupting chemical, alters the first trimester placental methylome and transcriptome in women. Scientific Reports 8:6086.
Health NCCfM. Attention deficit hyperactivity disorder: Diagnosis and management of adhd in children, young people and adults. 2018, British Psychological Society.
Hechtman L. 1996. Families of children with attention deficit hyperactivity disorder: A review. The Canadian Journal of Psychiatry 41:350-360.
Hsia JM. 2019. Quantitation of environmental pollutants in urine and serum using ultra-performance liquid chromatography/tandem mass spectrometry:National Taiwan University.
Huang H-B, Pan W-H, Chang J-W, Chiang H-C, Guo YL, Jaakkola JJ, et al. 2017. Does exposure to phthalates influence thyroid function and growth hormone homeostasis? The taiwan environmental survey for toxicants (test) 2013. Environmental research 153:63-72.
Huang H-B, Kuo P-H, Su P-H, Sun C-W, Chen WJ, Wang S-L. 2019. Prenatal and childhood exposure to phthalate diesters and neurobehavioral development in a 15-year follow-up birth cohort study. Environmental research 172:569-577.
Huang HB, Chen HY, Su PH, Huang PC, Sun CW, Wang CJ, et al. 2015. Fetal and childhood exposure to phthalate diesters and cognitive function in children up to 12 years of age: Taiwanese maternal and infant cohort study. PLoS One 10:e0131910.
Huang P-C, Tsai C-H, Liang W-Y, Li S-S, Huang H-B, Kuo P-L. 2016. Early phthalates exposure in pregnant women is associated with alteration of thyroid hormones. PloS one 11.
Instanes JT, Halmoy A, Engeland A, Haavik J, Furu K, Klungsoyr K. 2017. Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biological psychiatry 81:452-459.
Johns LE, Ferguson KK, Soldin OP, Cantonwine DE, Rivera-González LO, Del Toro LVA, et al. 2015. Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: A longitudinal analysis. Reproductive Biology and Endocrinology 13:4.
Kim BN, Cho SC, Kim Y, Shin MS, Yoo HJ, Kim JW, et al. 2009. Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biological psychiatry 66:958-963.
Kim JI, Hong YC, Shin CH, Lee YA, Lim YH, Kim BN. 2017. The effects of maternal and children phthalate exposure on the neurocognitive function of 6-year-old children. Environ Res 156:519-525.
Koch HM, Lorber M, Christensen KL, Palmke C, Koslitz S, Bruning T. 2013. Identifying sources of phthalate exposure with human biomonitoring: Results of a 48h fasting study with urine collection and personal activity patterns. Int J Hyg Environ Health 216:672-681.
Kooij J, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balazs J, et al. 2019. Updated european consensus statement on diagnosis and treatment of adult adhd. European psychiatry 56:14-34.
Koppen G, Govarts E, Vanermen G, Voorspoels S, Govindan M, Dewolf MC, et al. 2019. Mothers and children are related, even in exposure to chemicals present in common consumer products. Environ Res 175:297-307.
Levy F, Hay DA, McSTEPHEN M, Wood C, Waldman I. 1997. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child & Adolescent Psychiatry 36:737-744.
Lichtenstein JD, Flaro L, Baldwin FS, Rai J, Erdodi LA. 2019. Further evidence for embedded performance validity tests in children within the conners’ continuous performance test–second edition. Developmental neuropsychology 44:159-171.
Marin-Mendez J, Alvarez-Gomez M, Borra-Ruiz M, Vallejo-Valdivielso M, Diez-Suarez A, Soutullo-Esperon C. 2018. Attention deficit hyperactivity disorder in preschool age children. Its epidemiological prevalence in navarra and la rioja, spain. Revista de neurologia 66:S115-S120.
Meeker JD, Calafat AM, Hauser R. 2007. Di (2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environmental health perspectives 115:1029-1034.
Meeker JD, Ferguson KK. 2011. Relationship between urinary phthalate and bisphenol a concentrations and serum thyroid measures in us adults and adolescents from the national health and nutrition examination survey (nhanes) 2007–2008. Environmental health perspectives 119:1396-1402.
Millichap JG. 2008. Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics 121:e358-e365.
Moog NK, Entringer S, Heim C, Wadhwa PD, Kathmann N, Buss C. 2017. Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience 342:68-100.
Morreale de Escobar G, Obregon MJ, Escobar del Rey F. 2004. Role of thyroid hormone during early brain development. European journal of endocrinology 151 Suppl 3:U25-37.
Munkvold LH, Manger T, Lundervold AJ. 2014. Conners’ continuous performance test (ccpt-ii) in children with adhd, odd, or a combined adhd/odd diagnosis. Child Neuropsychology 20:106-126.
Neuman RJ, Hudziak JJ, Heath A, Reich W, Bucholz KK, Madden PA, et al. 2001. Latent class analysis of adhd and comorbid symptoms in a population sample of adolescent female twins. The Journal of Child Psychology and Psychiatry and Allied Disciplines 42:933-942.
Pacyga DC, Sathyanarayana S, Strakovsky RS. 2019. Dietary predictors of phthalate and bisphenol exposures in pregnant women. Advances in Nutrition 10:803-815.
Park C, Choi W, Hwang M, Lee Y, Kim S, Yu S, et al. 2017. Associations between urinary phthalate metabolites and bisphenol a levels, and serum thyroid hormones among the korean adult population-korean national environmental health survey (konehs) 2012–2014. Science of the total environment 584:950-957.
Park S, Kim BN, Cho SC, Kim Y, Kim JW, Lee JY, et al. 2014. Association between urine phthalate levels and poor attentional performance in children with attention-deficit hyperactivity disorder with evidence of dopamine gene-phthalate interaction. International journal of environmental research and public health 11:6743-6756.
Pliszka S, Issues AWGoQ. 2007. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 46:894-921.
Romano ME, O’Connell K, Du M, Rehm CD, Kantor ED. 2019. Use of dietary supplements in relation to urinary phthalate metabolite concentrations: Results from the national health and nutrition examination survey. Environmental research 172:437-443.
Shaked D, Faulkner LM, Tolle K, Wendell CR, Waldstein SR, Spencer RJ. 2019. Reliability and validity of the conners’ continuous performance test. Applied Neuropsychology: Adult:1-10.
Stevenson J. 1992. Evidence for a genetic etiology in hyperactivity in children. Behavior genetics 22:337-344.
Tallberg P, Råstam M, Wenhov L, Eliasson G, Gustafsson P. 2019. Incremental clinical utility of continuous performance tests in childhood adhd–an evidence‐based assessment approach. Scandinavian journal of psychology 60:26-35.
Tandon M, Pergjika A. 2017. Attention deficit hyperactivity disorder in preschool-age children. Child and Adolescent Psychiatric Clinics 26:523-538.
Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. 2004. European clinical guidelines for hyperkinetic disorder–first upgrade. European child & adolescent psychiatry 13:i7-i30.
Thapar A, Cooper M. 2016. Attention deficit hyperactivity disorder. Lancet (London, England) 387:1240-1250.
Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, et al. 2010. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: A genome-wide analysis. The Lancet 376:1401-1408.
Yao H-y, Han Y, Gao H, Huang K, Ge X, Xu Y-y, et al. 2016. Maternal phthalate exposure during the first trimester and serum thyroid hormones in pregnant women and their newborns. Chemosphere 157:42-48.
Zhang Q, Chen X-Z, Huang X, Wang M, Wu J. 2019. The association between prenatal exposure to phthalates and cognition and neurobehavior of children-evidence from birth cohorts. Neurotoxicology.